Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 15 | 2018 | 243 | 2.150 |
Why?
|
| Thrombectomy | 6 | 2018 | 30 | 1.400 |
Why?
|
| Cerebral Angiography | 4 | 2016 | 29 | 1.330 |
Why?
|
| Intracranial Aneurysm | 3 | 2016 | 33 | 1.250 |
Why?
|
| Intracranial Hemorrhages | 4 | 2017 | 11 | 1.060 |
Why?
|
| Brain Ischemia | 8 | 2018 | 61 | 1.060 |
Why?
|
| Intracranial Arteriovenous Malformations | 2 | 2016 | 9 | 0.930 |
Why?
|
| Arteriovenous Fistula | 2 | 2016 | 10 | 0.930 |
Why?
|
| Aneurysm, Ruptured | 2 | 2016 | 12 | 0.920 |
Why?
|
| Endovascular Procedures | 8 | 2018 | 27 | 0.900 |
Why?
|
| Embolization, Therapeutic | 3 | 2014 | 53 | 0.860 |
Why?
|
| Arterial Occlusive Diseases | 3 | 2017 | 8 | 0.730 |
Why?
|
| Cerebrovascular Disorders | 3 | 2015 | 104 | 0.570 |
Why?
|
| Patient Transfer | 1 | 2017 | 24 | 0.520 |
Why?
|
| Neurosurgery | 2 | 2015 | 32 | 0.450 |
Why?
|
| Informed Consent | 1 | 2015 | 21 | 0.450 |
Why?
|
| Periodicals as Topic | 2 | 2015 | 31 | 0.450 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2014 | 578 | 0.450 |
Why?
|
| Self-Help Groups | 1 | 2014 | 7 | 0.440 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2014 | 38 | 0.430 |
Why?
|
| Humans | 27 | 2018 | 23178 | 0.420 |
Why?
|
| Social Media | 1 | 2014 | 45 | 0.410 |
Why?
|
| Vascular Access Devices | 1 | 2013 | 4 | 0.410 |
Why?
|
| Cerebral Arteries | 1 | 2013 | 21 | 0.410 |
Why?
|
| Middle Aged | 12 | 2018 | 7972 | 0.370 |
Why?
|
| Checklist | 1 | 2011 | 33 | 0.350 |
Why?
|
| Intraoperative Complications | 1 | 2011 | 56 | 0.340 |
Why?
|
| Female | 14 | 2018 | 13133 | 0.340 |
Why?
|
| Predictive Value of Tests | 3 | 2017 | 442 | 0.320 |
Why?
|
| Aged | 11 | 2018 | 7653 | 0.320 |
Why?
|
| Male | 14 | 2018 | 12650 | 0.310 |
Why?
|
| Adult | 7 | 2018 | 6951 | 0.280 |
Why?
|
| Retrospective Studies | 7 | 2018 | 2990 | 0.270 |
Why?
|
| Aged, 80 and over | 7 | 2018 | 3864 | 0.260 |
Why?
|
| Morbidity | 2 | 2016 | 50 | 0.230 |
Why?
|
| False Positive Reactions | 2 | 2017 | 29 | 0.230 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 1430 | 0.230 |
Why?
|
| Stents | 3 | 2018 | 75 | 0.220 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2016 | 28 | 0.220 |
Why?
|
| Practice Guidelines as Topic | 2 | 2015 | 235 | 0.200 |
Why?
|
| Thrombolytic Therapy | 3 | 2014 | 44 | 0.200 |
Why?
|
| Prognosis | 2 | 2016 | 730 | 0.190 |
Why?
|
| Young Adult | 3 | 2018 | 1656 | 0.170 |
Why?
|
| Adolescent | 3 | 2018 | 1884 | 0.170 |
Why?
|
| Tissue Plasminogen Activator | 3 | 2015 | 41 | 0.160 |
Why?
|
| Clinical Trials as Topic | 3 | 2015 | 192 | 0.160 |
Why?
|
| Angiography, Digital Subtraction | 2 | 2016 | 9 | 0.150 |
Why?
|
| Fibrinolytic Agents | 3 | 2017 | 58 | 0.140 |
Why?
|
| Embolectomy | 2 | 2015 | 3 | 0.140 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 244 | 0.140 |
Why?
|
| Societies, Medical | 2 | 2015 | 118 | 0.140 |
Why?
|
| Treatment Outcome | 5 | 2018 | 2943 | 0.130 |
Why?
|
| Evidence-Based Medicine | 2 | 2015 | 137 | 0.130 |
Why?
|
| Rupture, Spontaneous | 1 | 2016 | 3 | 0.120 |
Why?
|
| Neurologic Examination | 1 | 2016 | 82 | 0.120 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 27 | 0.120 |
Why?
|
| Subdural Effusion | 1 | 2015 | 6 | 0.120 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2015 | 7 | 0.120 |
Why?
|
| Research Report | 1 | 2015 | 5 | 0.120 |
Why?
|
| Writing | 1 | 2015 | 17 | 0.110 |
Why?
|
| Research Personnel | 1 | 2015 | 17 | 0.110 |
Why?
|
| Posterior Cerebral Artery | 1 | 2014 | 3 | 0.110 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 29 | 0.110 |
Why?
|
| Aneurysm | 1 | 2014 | 10 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2016 | 310 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2014 | 51 | 0.110 |
Why?
|
| Neurosurgical Procedures | 1 | 2015 | 115 | 0.100 |
Why?
|
| Psychometrics | 1 | 2014 | 184 | 0.100 |
Why?
|
| False Negative Reactions | 1 | 2013 | 13 | 0.100 |
Why?
|
| Tertiary Care Centers | 1 | 2013 | 66 | 0.100 |
Why?
|
| Hospitalization | 1 | 2015 | 287 | 0.100 |
Why?
|
| Pilot Projects | 1 | 2013 | 369 | 0.090 |
Why?
|
| Angioplasty | 2 | 2010 | 5 | 0.090 |
Why?
|
| Injections, Intra-Arterial | 1 | 2011 | 5 | 0.090 |
Why?
|
| Transportation of Patients | 1 | 2011 | 4 | 0.090 |
Why?
|
| Child | 1 | 2015 | 1160 | 0.090 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 778 | 0.080 |
Why?
|
| Chicago | 1 | 2013 | 847 | 0.080 |
Why?
|
| Assisted Circulation | 1 | 2010 | 2 | 0.080 |
Why?
|
| Risk Factors | 1 | 2016 | 2020 | 0.080 |
Why?
|
| Radiography | 1 | 2011 | 521 | 0.080 |
Why?
|
| Hypothermia, Induced | 1 | 2010 | 15 | 0.080 |
Why?
|
| Surveys and Questionnaires | 1 | 2014 | 1037 | 0.080 |
Why?
|
| Angioplasty, Balloon | 1 | 2009 | 14 | 0.080 |
Why?
|
| Prospective Studies | 1 | 2013 | 1512 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 6 | 1 | 2008 | 1 | 0.070 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2008 | 3 | 0.070 |
Why?
|
| Human Growth Hormone | 1 | 2008 | 4 | 0.070 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2008 | 2 | 0.070 |
Why?
|
| Intracranial Thrombosis | 1 | 2008 | 6 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2008 | 242 | 0.060 |
Why?
|
| Single-Blind Method | 1 | 2018 | 88 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2017 | 32 | 0.030 |
Why?
|
| Time-to-Treatment | 1 | 2017 | 27 | 0.030 |
Why?
|
| Cerebral Infarction | 1 | 2017 | 113 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 294 | 0.030 |
Why?
|
| Disability Evaluation | 1 | 2017 | 225 | 0.030 |
Why?
|
| Time Factors | 2 | 2011 | 1264 | 0.030 |
Why?
|
| Reperfusion | 1 | 2015 | 7 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2014 | 40 | 0.030 |
Why?
|
| Disease Management | 1 | 2015 | 98 | 0.030 |
Why?
|
| Speech Disorders | 1 | 2014 | 10 | 0.030 |
Why?
|
| Forecasting | 1 | 2014 | 79 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2014 | 40 | 0.030 |
Why?
|
| Patient Selection | 1 | 2015 | 170 | 0.030 |
Why?
|
| Animals | 2 | 2010 | 3271 | 0.020 |
Why?
|
| Registries | 1 | 2011 | 174 | 0.020 |
Why?
|
| United States | 1 | 2015 | 1801 | 0.020 |
Why?
|
| Middle Cerebral Artery | 1 | 2009 | 8 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 2009 | 14 | 0.020 |
Why?
|
| Acute Disease | 1 | 2009 | 163 | 0.020 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2008 | 1 | 0.020 |
Why?
|
| Cyclin D | 1 | 2008 | 1 | 0.020 |
Why?
|
| Organic Anion Transporters, Sodium-Dependent | 1 | 2008 | 2 | 0.020 |
Why?
|
| Cyclins | 1 | 2008 | 5 | 0.020 |
Why?
|
| Symporters | 1 | 2008 | 6 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2008 | 11 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2008 | 10 | 0.020 |
Why?
|
| Ligation | 1 | 2008 | 36 | 0.020 |
Why?
|
| Liver Regeneration | 1 | 2008 | 24 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 95 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2008 | 161 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2008 | 164 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2008 | 144 | 0.020 |
Why?
|
| Mice | 1 | 2008 | 1240 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 1467 | 0.010 |
Why?
|